Evening Primrose Oil

Posted on 2005-12-30 20:01:01 in Fatty Acids, Lipids & Oils |

GENERAL DESCRIPTION:

Evening primrose oil (EPO) is derived from the seeds of the evening primrose plant (Oenothera biennis), native to North America, Europe and parts of Asia. Native Americans used EPO to treat bruises, hemorrhoids, sore throats, and stomach aches. The active ingredient in EPO is gamma linolenic acid (GLA), an omega-6 essential fatty acid that the body converts to the anti-inflammatory prostaglandin E1 (PGE1).

ROLE IN ANTIAGING:

EPO may be considered as an important botanical in combatting the general effects of aging. The body loses its ability to convert dietary fats into GLA with age, thus EPO may be helpful in age-related conditions resulting from GLA deficiency. As such, EPO is often used to relieve the symptoms of rheumatoid arthritis. Some research suggests that EPO may be of benefit to diabetics, as the GLA in EPO has been shown to prevent, and in some cases, reverse nerve damage (neuropathy), which is a common complication of the disease. As GLA helps to keep nerves healthy and combat inflammation, EPO may be helpful in multiple sclerosis. The supplement is also recommended for people suffering from Alzheimer’s-related memory problems, as GLA boosts the transmission of nerve impulses.  Some studies have produced evidence to suggest that EPO may lower cholesterol levels, however other studies have produced conflicting results. EPO is often marketed as a treatment for PMS, however research to support these claims is inconclusive.

DEFICIENCY SYMPTOMS:

Not applicable

THERAPEUTIC DAILY AMOUNT:

The optimal daily intake of EPO is yet to be established. A typical daily dose is 3,000- 6,000 mg, which contains roughly 270-540 mg of GLA. Taking EPO with foods boosts GLA absorption. Some experts recommend taking a supplement containing magnesium, zinc, vitamin C, niacin, and vitamin B6 at the same time as EPO, as the body needs all of these nutrients in order to produce PGE1.

MAXIMUM SAFE LEVEL:

A maximum safe level of EPO has not been established. Nor is there any evidence to confirm the safety of long-term use of EPO, however there have been no reports of any significant toxic side effects associated with EPO.

SIDE EFFECTS/CONTRAINDICATIONS:

EPO may worsen symptoms of temporal lobe epilepsy. It should also be avoided by schizophrenics who are prescribed phenothiazine epileptogenic drugs.

Health Headlines MORE »

Researchers from Norway suggest a mechanism by which stress may make a person fat, and being obese may create stress.
Swedish researchers report that people who are short on sleep experience greater levels of hunger.
Among women with Generalized Anxiety Disorder (GAD), regular physical activity helps to reduce anxiety, irritability, feelings of tension, low energy and pain.
For every 100 mg per-day increase in magnesium in the diet, stroke risk may decline by up to 9%.
The best male marathon runners over age 65, and the best female marathon runners over age 45, continue to consistently improve their performance.
UCLA-led team safely uses human embryonic stem cells to treat macular degeneration.
First-of-its-kind study reports that indoor air in offices is an important source of worker exposure to potentially toxic substances.
Twenty percent of Americans ages 18+ experienced a diagnosable mental, behavioral, or emotional disorder in 2010.
In a lab animal model, vitamin D reduced the effects of aging in the eyes and improved the vision of older animals.
For the first time ever, stem cells from umbilical cords have been converted into other types of cells, paving the way for new treatment options for spinal cord
ANTI-AGING TIP OF THE DAY
Exercise Your Anti-Cancer Option
Among women, regular exercise in their 40s slashes breast cancer risk. Among men, routine physical activity exerts a protective effect against prostate cancer.
    US National Cancer Institute(Maryland, USA) researchers have found that regular moderate-to-vigorous exercise in the ten-year period preceding menopause may help reduce the risk of breast cancer later in life. Studying 118,899 postmenopausal women...